Evidence map›Paper›PMID 26364189›Full record

ArticleCurrent microbiology2016

Sub-Inhibitory Concentration of Piperacillin-Tazobactam May be Related to Virulence Properties of Filamentous Escherichia coli.

João Paulo Lopes de Andrade, Luiz de Macêdo Farias, João Fernando Gonçalves Ferreira, Oscar Bruna-Romero, Daniele da Glória de Souza, Maria Auxiliadora Roque de Carvalho, Kênia Valéria dos Santos

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Insights into the Metabolic Adaptations of a Carbapenem-ResistantInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Sub-Inhibitory Concentrations of Amoxicillin and Tylosin Affect the Biofilm Formation and Virulence ofInternational journal of environmental research and public health · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Sub-Optimal Treatment of Bacterial Biofilms.Antibiotics (Basel, Switzerland) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

João Paulo Lopes de AndradeDepartamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627 - Pampulha, C.P. 486, Belo Horizonte, MG, CEP 31270-901, Brazil.
Luiz de Macêdo FariasDepartamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627 - Pampulha, C.P. 486, Belo Horizonte, MG, CEP 31270-901, Brazil.
João Fernando Gonçalves FerreiraDepartamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627 - Pampulha, C.P. 486, Belo Horizonte, MG, CEP 31270-901, Brazil.
Oscar Bruna-RomeroDepartamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627 - Pampulha, C.P. 486, Belo Horizonte, MG, CEP 31270-901, Brazil.
Daniele da Glória de SouzaDepartamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627 - Pampulha, C.P. 486, Belo Horizonte, MG, CEP 31270-901, Brazil.
Maria Auxiliadora Roque de CarvalhoDepartamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627 - Pampulha, C.P. 486, Belo Horizonte, MG, CEP 31270-901, Brazil.
Kênia Valéria dos SantosDepartamento de Patologia, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo, Av. Marechal Campos 1468, Bairro Maruípe, Vitória, ES, CEP: 29043-900, Brazil. keniavaleria@gmail.com.
Universidade Federal de Minas Gerais · BRUniversidade Federal de Santa Catarina · BRUniversidade Federal do Espírito Santo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sub-inhibitory concentrations of antibiotics are always generated as a consequence of antimicrobial therapy and the effects of such residual products in bacterial morphology are well documented, especially the filamentation generated by beta-lactams. The aim of this study was to investigate some morphological and pathological aspects (virulence factors) of Escherichia coli cultivated under half-minimum inhibitory concentration (1.0 µg/mL) of piperacillin-tazobactam (PTZ sub-MIC). PTZ sub-MIC promoted noticeable changes in the bacterial cells which reach the peak of morphological alterations (filamentation) and complexity at 16 h of antimicrobial exposure. Thereafter the filamentous cells and a control one, not treated with PTZ, were comparatively tested for growth curve; biochemical profile; oxidative stress tolerance; biofilm production and cell hydrophobicity; motility and pathogenicity in vivo. PTZ sub-MIC attenuated the E. coli growth rate, but without changes in carbohydrate fermentation or in traditional biochemical tests. Overall, the treatment of E. coli with sub-MIC of PTZ generated filamentous forms which were accompanied by the inhibition of virulence factors such as the oxidative stress response, biofilm formation, cell surface hydrophobicity, and motility. These results are consistent with the reduced pathogenicity observed for the filamentous E. coli in the murine model of intra-abdominal infection. In other words, the treatment of E. coli with sub-MIC of PTZ suggests a decrease in their virulence.

Indexed as

AnimalsAnti-Bacterial AgentsBiofilmsDisease Models, AnimalEscherichia coliEscherichia coli InfectionsIntraabdominal InfectionsLocomotionMetabolismMiceMicrobial Sensitivity TestsPenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug CombinationVirulenceAnti-Bacterial AgentsPenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug Combination

Identifiers

PMID26364189
OpenAlexW1708183747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.